Celularity, Inc. (CELU)
1.56
+0.10
(+6.85%)
USD |
NASDAQ |
Oct 09, 16:00
1.59
+0.03
(+1.92%)
After-Hours: 20:00
Celularity Cash from Operations (Quarterly) : 1.447M for March 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.447M |
| December 31, 2025 | -5.103M |
| September 30, 2025 | -4.159M |
| June 30, 2025 | -0.999M |
| March 31, 2025 | -2.993M |
| December 31, 2024 | 1.594M |
| September 30, 2024 | -0.144M |
| June 30, 2024 | -3.448M |
| March 31, 2024 | -4.403M |
| December 31, 2023 | -4.341M |
| September 30, 2023 | -8.322M |
| June 30, 2023 | -11.03M |
| March 31, 2023 | -15.00M |
| December 31, 2022 | -29.58M |
| September 30, 2022 | -37.72M |
| Date | Value |
|---|---|
| June 30, 2022 | -36.32M |
| March 31, 2022 | -34.25M |
| December 31, 2021 | -32.04M |
| September 30, 2021 | -34.77M |
| June 30, 2021 | -18.20M |
| March 31, 2021 | -25.08M |
| December 31, 2020 | -16.83M |
| September 30, 2020 | -45.59M |
| June 30, 2020 | -0.2244M |
| March 31, 2020 | -0.5496M |
| December 31, 2019 | -0.2238M |
| September 30, 2019 | -0.6792M |
| June 30, 2019 | -0.1941M |
| March 31, 2019 | -0.0007M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -14.15M |
| Exicure, Inc. | -0.887M |
| Century Therapeutics, Inc. | -19.83M |
| Absci Corp. | -27.56M |
| Cardio Diagnostics Holdings, Inc. | -1.342M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -7.342M |
| Free Cash Flow | -8.814M |
| Free Cash Flow Per Share (Quarterly) | 0.0478 |
| Free Cash Flow to Equity (Quarterly) | 8.08M |
| Free Cash Flow to Firm (Quarterly) | 1.799M |
| Free Cash Flow Yield | -20.64% |